Literature DB >> 2443933

Acute and chronic ethanol treatments alter GABA receptor-operated chloride channels.

A M Allan1, R A Harris.   

Abstract

The effect of ethanol exposure in vitro on the GABA receptor-operated chloride channel was evaluated by monitoring 36Cl- influx in a membrane vesicle suspension (microsacs) prepared from mouse cerebellum. These experiments directly demonstrate ethanol augmentation of muscimol-stimulated chloride flux. DBA/2J mice were made tolerant to and dependent on ethanol by administration of an ethanol containing liquid diet for 7 days. Exposure to physiologically relevant concentrations of ethanol (10-45 mM) in vitro potentiated muscimol stimulation of 36Cl- uptake in control (pair-fed) membranes, but had no effect on cerebellar microsacs from tolerant/dependent mice. Muscimol stimulation of 36Cl- uptake was not different for pair-fed and ethanol-treated mice. Augmentation of muscimol-induced 36Cl- flux by in vitro ethanol was abolished by a single 4 g/kg injection of ethanol. This "acute tolerance" occurred within 5 min and disappeared within 24 hr after ethanol treatment. The reduced sensitivity of ethanol treated (chronic and acute) mice to ethanol potentiation of muscimol stimulated 36Cl- uptake offers a biochemical correlate to the phenomenon of ethanol tolerance. Moreover, the findings suggest that this biochemical tolerance develops rapidly following a single hypnotic dose of ethanol.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2443933     DOI: 10.1016/0091-3057(87)90192-4

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  37 in total

Review 1.  Protein kinase C isozymes and addiction.

Authors:  M Foster Olive; Robert O Messing
Journal:  Mol Neurobiol       Date:  2004-04       Impact factor: 5.590

Review 2.  Identification and management of alcohol withdrawal syndrome.

Authors:  Antonio Mirijello; Cristina D'Angelo; Anna Ferrulli; Gabriele Vassallo; Mariangela Antonelli; Fabio Caputo; Lorenzo Leggio; Antonio Gasbarrini; Giovanni Addolorato
Journal:  Drugs       Date:  2015-03       Impact factor: 9.546

Review 3.  Neuroprotective and abstinence-promoting effects of acamprosate: elucidating the mechanism of action.

Authors:  Philippe De Witte; John Littleton; Philippe Parot; George Koob
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

4.  A strategy of escalating doses of benzodiazepines and phenobarbital administration reduces the need for mechanical ventilation in delirium tremens.

Authors:  Jeffrey A Gold; Binaya Rimal; Anna Nolan; Lewis S Nelson
Journal:  Crit Care Med       Date:  2007-03       Impact factor: 7.598

Review 5.  Stress, ethanol, and neuroactive steroids.

Authors:  Giovanni Biggio; Alessandra Concas; Paolo Follesa; Enrico Sanna; Mariangela Serra
Journal:  Pharmacol Ther       Date:  2007-05-08       Impact factor: 12.310

6.  A comparison of the effect of lorazepam on memory in heavy and low social drinkers.

Authors:  J M Nichols; F Martin; K C Kirkby
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Behavioral and neurochemical changes caused by repeated ethanol and cocaine administration.

Authors:  M Pecins-Thompson; J Peris
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Changes in GABA(A) receptor gene expression associated with selective alterations in receptor function and pharmacology after ethanol withdrawal.

Authors:  Enrico Sanna; Maria Cristina Mostallino; Fabio Busonero; Giuseppe Talani; Stefania Tranquilli; Manuel Mameli; Saturnino Spiga; Paolo Follesa; Giovanni Biggio
Journal:  J Neurosci       Date:  2003-12-17       Impact factor: 6.167

Review 9.  How adaptation of the brain to alcohol leads to dependence: a pharmacological perspective.

Authors:  Peter Clapp; Sanjiv V Bhave; Paula L Hoffman
Journal:  Alcohol Res Health       Date:  2008

10.  Changes in intrinsic inhibition in isolated hippocampal slices during ethanol withdrawal; lack of correlation with withdrawal hyperexcitability.

Authors:  M A Whittington; H J Little; J D Lambert
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.